disease

Type 2 Diabetes

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Type 2 Diabetes: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

728Connections

0Hypotheses

1Analyses

50Outgoing

50Incoming

0Experiments

1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

Disease Info

Associated Genes	ADRA2A, AGING, AKT, AKT1, ALZHEIMER, ANXIETY, APOE, APOE4
Therapeutic Agents	Exendin-4, Gliflozins, Metformin, METFORMIN, Postbiotics, Tirzepatide
KG Connections	707 knowledge graph edges
Databases	OMIM Orphanet ClinicalTrials PubMed

Pathway Diagram

graph TD
    Type_2_Diabetes["Type 2 Diabetes"]
    Insulin_Resistance{"Insulin Resistance"}
    Type_2_Diabetes -->|"associated_with"| Insulin_Resistance
    Diabetes{"Diabetes"}
    Type_2_Diabetes -->|"therapeutic_target"| Diabetes
    Oxidative_Stress["Oxidative Stress"]
    Type_2_Diabetes -->|"activates"| Oxidative_Stress
    Als{"Als"}
    Als -->|"regulates"| Type_2_Diabetes
    INSULIN_RESISTANCE(["INSULIN RESISTANCE"])
    INSULIN_RESISTANCE -->|"associated_with"| Type_2_Diabetes
    style Type_2_Diabetes fill:#1a3a4a,stroke:#ef5350,stroke-width:3px,color:#e0e0e0

Outgoing (163)

Target	Relation	Type	Str
Insulin Resistance	associated_with	disease	1.00
Diabetes	therapeutic_target	disease	1.00
Insulin Resistance	therapeutic_target	disease	1.00
Diabetes	associated_with	disease	1.00
Oxidative Stress	activates	pathway	1.00
Insulin Resistance	activates	disease	0.95
Heart Failure	risk_factor_for	disease	0.90
INFLAMMATION	causes	process	0.90
Chronic Kidney Disease	risk_factor_for	disease	0.90
Alzheimer's disease	risk_factor_for	disease	0.90
Lipid Metabolism	therapeutic_target	pathway	0.90
ALZHEIMER'S DISEASE	risk_factor_for	disease	0.88
Peripheral Low-Grade Inflammation	causes	process	0.85
BMAL1	downregulates	gene	0.85
Diabetes	activates	disease	0.85
NEUROINFLAMMATION	causes	process	0.85
Insulin Resistance	regulates	disease	0.85
Diabetic Complications	causes	disease	0.85
Alzheimer's Disease	risk_factor_for	disease	0.80
Cholesterol	activates	pathway	0.80
Oxidative Stress	therapeutic_target	pathway	0.80
Microrna	regulates	pathway	0.80
Mitophagy	activates	pathway	0.80
Nf-Κb	inhibits	pathway	0.70
Mtor	regulates	pathway	0.70
Apoptosis	protects_against	pathway	0.70
Insulin Signaling	contributes_to	pathway	0.70
Autophagy	contributes_to	pathway	0.70
Epigenetic	associated_with	pathway	0.70
Cholesterol	associated_with	pathway	0.70
Oxidative Stress	regulates	pathway	0.70
Epigenetic	treats	pathway	0.70
Mapk	therapeutic_target	pathway	0.70
Microrna	biomarker_for	pathway	0.70
Dysbiosis	therapeutic_target	pathway	0.70
Microbiota	associated_with	pathway	0.70
Differentiation	regulates	pathway	0.70
Oxidative Stress	causes	pathway	0.70
Autophagy	inhibits	pathway	0.70
Lipid Metabolism	regulates	pathway	0.70
Apoptosis	activates	pathway	0.70
Alzheimer's disease	associated_with	disease	0.70
Autophagy	therapeutic_target	pathway	0.70
Apoptosis	therapeutic_target	pathway	0.70
Autophagy	activates	pathway	0.70
Lipid Metabolism	inhibits	pathway	0.70
Diabetes	interacts_with	disease	0.65
Diabetes	causes	disease	0.65
Diabetes	regulates	disease	0.65
Insulin Resistance	causes	disease	0.65

Incoming (565)

Source	Relation	Type	Str
Diabetes	activates	disease	1.00
Als	regulates	disease	1.00
INSULIN RESISTANCE	therapeutic_target	gene	1.00
ALZHEIMER	activates	gene	1.00
Als	therapeutic_target	disease	1.00
Diabetes	regulates	disease	1.00
Diabetes	therapeutic_target	disease	1.00
DIABETES MELLITUS	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
INSULIN RESISTANCE	activates	gene	1.00
DIABETES MELLITUS	therapeutic_target	gene	1.00
Diabetes	inhibits	disease	1.00
INSULIN RESISTANCE	associated_with	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
Als	inhibits	disease	1.00
INFLAMMATION	regulates	gene	1.00
ROS	activates	gene	1.00
DIABETES MELLITUS	associated_with	gene	1.00
Diabetes	associated_with	disease	1.00
Obesity	associated_with	disease	1.00
Als	associated_with	disease	1.00
Als	treats	disease	1.00
Tirzepatide	treats	drug	0.95
INSULIN RESISTANCE	regulates	gene	0.95
Gliflozins	treats	drug	0.95
AGING	associated_with	gene	0.95
INFLAMMATION	inhibits	gene	0.95
GENES	associated_with	gene	0.95
Exendin-4	treats	drug	0.95
Obesity	therapeutic_target	disease	0.95
MITOCHONDRIAL DYSFUNCTION	activates	gene	0.95
Inflammation	activates	disease	0.95
Obesity	regulates	disease	0.95
Cardiovascular	associated_with	disease	0.95
ALZHEIMER'S DISEASE	activates	gene	0.95
Metabolic Syndrome	associated_with	disease	0.95
Inflammation	regulates	disease	0.95
INFLAMMATION	associated_with	gene	0.95
Cancer	associated_with	disease	0.95
Plasma Proteins	associated_with	biomarker	0.95
glycated haemoglobin	biomarker_for	phenotype	0.90
METFORMIN	treats	drug	0.90
CIRCADIAN DISRUPTION	associated_with	entity	0.90
SGLT2	biomarker_for	protein	0.90
Metformin	treats	drug	0.90
MITOPHAGY	activates	gene	0.85
INFLAMMATION	therapeutic_target	gene	0.85
AMPK	therapeutic_target	gene	0.85
Cardiovascular	activates	disease	0.85
Als	activates	disease	0.85

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

neurodegeneration | 2026-04-14 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The study demonstrates significant reduction in dementia risk (HR 0.63) with GLP

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Type 2 Diabetes in their description or question text

No additional research found